Why do men with prostate cancer discontinue active surveillance for definitive treatment? A mixed methods investigation

OBJECTIVES: To explore the personal and/or medical reasons patients on active surveillance (AS) have, or consider having, further definitive treatment for their prostate cancer. Research suggests up to 50% of patients on AS will discontinue within 5 years, though reasons for discontinuation from the...

Descripción completa

Detalles Bibliográficos
Autores principales: McIntosh, Megan, Opozda, Melissa J., O’Callaghan, Michael, Vincent, Andrew D., Galvão, Daniel A., Short, Camille E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540004/
https://www.ncbi.nlm.nih.gov/pubmed/35538736
http://dx.doi.org/10.1002/pon.5947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540004/
https://www.ncbi.nlm.nih.gov/pubmed/35538736
http://dx.doi.org/10.1002/pon.5947

Ejemplares similares